CAR20(NAP)-T Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR20(NAP)-T Therapy, covering 2024-05-09 to 2024-05-09. Get the full timeline:
Most recent: Clinical Trial Update: CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) [Phase 1, Phase 2]